Dysregulation of tumor suppressor genes such as TP53 and RB1, along with the activation of oncogenic signaling pathways like PI3K/AKT and MAPK, are thought to play critical roles in the metastatic cascade of SCLC [3,4]. The gene discussed is TP53; the disease is small cell lung carcinoma.